Acceleration of the gastrointestinal transit by polyethylene glycol effectively treats unconjugated hyperbilirubinaemia in Gunn rats

Gut

Volumn 59, Issue 3, 2010, Pages 373-380

  Cuperus, Frans J C ^a   Iemhoff, Arjan A ^a   Van Der Wulp, Mariette ^a   Havinga, Rick ^a   Verkade, Henkjan J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; LOPERAMIDE; MACROGOL; TETRAHYDROLIPSTATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; FECES; GASTROINTESTINAL TRANSIT; GUNN RAT; HYPERBILIRUBINEMIA; MALE; NONHUMAN; PHOTOTHERAPY; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIDIARRHEALS; BILE; BILIRUBIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; FECES; GASTROINTESTINAL TRANSIT; HYPERBILIRUBINEMIA; INTESTINE, SMALL; LOPERAMIDE; MALE; PHOTOTHERAPY; POLYETHYLENE GLYCOLS; RATS; RATS, GUNN;

EID: 77749318514     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2009.183921     Document Type: Article

References (41)

1. Crigler JF Jr, Najjar VA. Congenital familial nonhemolytic jaundice with kernicterus. Pediatrics 1952;10:169e80.
2. Shapiro SM. Definition of the clinical spectrum of kernicterus and bilirubin-induced neurologic dysfunction (BIND). J Perinatol 2005;25:54e9.
3. Ostrow JD. Photocatabolism of labeled bilirubin in the congenitally jaundiced (Gunn) rat. J Clin Invest 1971;50:707e18.
4. Van der Veere CN, Sinaasappel M, McDonagh AF, et al. Current therapy for Crigler-Najjar syndrome type 1: report of a world registry. Hepatology 1996;24:311e15.
5. Yohannan MD, Terry HJ, Littlewood JM. Long term phototherapy in Crigler-Najjar syndrome. Arch Dis Child 1983;58:460e2.
6. Kotal P, Van der Veere CN, Sinaasappel M, et al. Intestinal excretion of unconjugated bilirubin in man and rats with inherited unconjugated hyperbilirubinemia. Pediatr Res 1997;42:195e200.
7. Lester R, Schmid R. Intestinal absorption of bile pigments. I. The enterohepatic circulation of bilirubin in the rat. J Clin Invest 1963;42:736e46.
8. Lester R, Schmid R. Intestinal absorption of bile pigments. II. Bilirubin absorption in man. N Engl J Med 1963;269:178e82.
9. Schmid R, Hammaker L. Metabolism and disposition of C14-Bilirubin in congenital nonhemolytic jaundice. J Clin Invest 1963;42: 1720e34.
10. Cuperus FJC, Hafkamp AM, Havinga R, et al. Effective treatment of unconjugated hyperbilirubinemia with oral bile salts in Gunn rats. Gastroenterology 2009;136:673e82.
11. Odell GB, Gutcher GR, Whitington PF, et al. Enteral administration of agar as an effective adjunct to phototherapy of neonatal hyperbilirubinemia. Pediatr Res 1983;17:810e14.
12. Lester R, Hammaker L, Schmid R. A new therapeutic approach to unconjugated hyperbilirubinaemia. Lancet 1962;2:1257.
13. Davis DR, Yeary RA, Lee K. Activated charcoal decreases plasma bilirubin levels in the hyperbilirubinemic rat. Pediatr Res 1983;17:208e9.
14. Van der Veere CN, Jansen PL, Sinaasappel M, et al. Oral calcium phosphate: a new therapy for Crigler-Najjar disease? Gastroenterology 1997;112:455e62.
15. Van der Veere CN, Schoemaker B, Bakker C, et al. Influence of dietary calcium phosphate on the disposition of bilirubin in rats with unconjugated hyperbilirubinemia. Hepatology 1996;24:620e6.
16. Vitek L, Muchova L, Zelenka J, et al. The effect of zinc salts on serum bilirubin levels in hyperbilirubinemic rats. J Pediatr Gastroenterol Nutr 2005;40:135e140.
17. Hafkamp AM, Havinga R, Sinaasappel M, et al. Effective oral treatment of unconjugated hyperbilirubinemia in Gunn rats. Hepatology 2005;41:526e34.
18. Kotal P, Vitek L, Fevery J. Fasting-related hyperbilirubinemia in rats: the effect of decreased intestinal motility. Gastroenterology 1996;111:217e23.
19. Bertini G, Dani C, Tronchin M, et al. Is breastfeeding really favoring early neonatal jaundice? Pediatrics 2001;107:E41.
20. Gilbert A, Herscher M. Sur les variations de la cholemie physiologique. Presse Med 1906;14:209e11.
21. Etzioni A, Shoshani G, Diamond E, et al. Unconjugated hyperbilirubinaemia in hypertrophic pyloric stenosis, an enigma. Z Kinderchir 1986;41:272e4.
22. Gartner M. Breastfeeding and Jaundice. J Perinatol 2001;21:S25e9.
23. Mihatsch WA, Hoegel J, Pohlandt F. Prebiotic oligosaccharides reduce stool viscosity and accelerate gastrointestinal transport in preterm infants. Acta Paediatr 2006;95:843e8.
24. Bisceglia M, Indrio F, Riezzo G, et al. The effect of prebiotics in the management of neonatal hyperbilirubinaemia. Acta Paediatr 2009;98:1579e81.
25. Lin M, Wu N, Aiken JH. Micellar high-performance liquid separation of serum bilirubin species with direct sample injection. J Liq Chromatogr 1995;18:1219e29.
26. Singh J, Bowers LD. Quantitative fractionation of serum bilirubin species by reversedphase high-performance liquid chromatography. J Chromatogr 1986;380:321e30.
27. Murphy GM, Billing BH, Baron DN. A fluorimetric and enzymatic method for the estimation of serum total bile acids. J Clin Pathol 1970;23:594e8.
28. Kotal P, Fevery J. Quantitation of urobilinogen in feces, urine, bile and serum by direct spectrophotometry of zinc complex. Clin Chim Acta 1991;202:1e9.
29. Lepage G, Roy CC. Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res 1986;27:114e20.
30. Whitmer DI, Gollan JL. Mechanisms and significance of fasting and dietary hyperbilirubinemia. Semin Liver Dis 1983;3:42e51.
31. De Carvalho M, Klaus MH, Merkatz RB. Frequency of breast-feeding and serum bilirubin concentration. Am J Dis Child 1982;136:737e8.
32. Wennberg RP, Schwartz R, Sweet AY. Early versus delayed feeding of low birth weight infants: effects on physiologic jaundice. J Pediatr 1966;68:860e6.
33. Wu PY, Teilmann P, Gabler M, et al. "Early" versus "late" feeding of low birth weight neonates: effect on serum bilirubin, blood sugar, and responses to glucagon and epinephrine tolerance tests. Pediatrics 1967;39:733e9.
34. Cottrell BH, Anderson GC. Rectal or axillary temperature measurement: effect on plasma bilirubin and intestinal transit of meconium. J Pediatr Gastroenterol Nutr 1984;3:734e9.
35. Costalos C, Kapiki A, Apostolou M, et al. The effect of a prebiotic supplemented formula on growth and stool microbiology of term infants. Early Hum Dev 2008;84:45e9.
36. Vitek L, Zelenka J, Zadinova M, et al. The impact of intestinal microflora on serum bilirubin levels. J Hepatol 2005;42:238e4.
37. Hafkamp AM, Havinga R, Ostrow JD, et al. Novel kinetic insights into treatment of unconjugated hyperbilirubinemia: phototherapy and orlistat treatment in Gunn rats. Pediatr Res 2006;59:506e12.
38. Di Palma JA, Cleveland MV, McGowan J, et al. An open-label study of chronic polyethylene glycol laxative use in chronic constipation. Aliment Pharmacol Ther 2007;25:703e8.
39. Nurko S, Youssef NN, Sabri M, et al. PEG3350 in the treatment of childhood constipation: a multicenter, double-blinded, placebo-controlled trial. J Pediatr 2008;153:254e61.
40. Klaschik E, Nauck F, Ostgathe C. Constipationemodern laxative therapy. Support Care Cancer 2003;11:679e85.
41. Ponz de Leon M, Iori R, Barbolini G, et al. Influence of small-bowel transit time on dietary cholesterol absorption in human beings. N Engl J Med 1982;307:102e3.